Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:17 PM
Ignite Modification Date:
2026-03-26 @ 3:17 PM
NCT ID:
NCT07364656
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 18 years
* Patients with a confirmed diagnosis of breast or colorectal cancer, either metastatic or non-metastatic
* Patients already receiving first-line therapy with a confirmed diagnosis of breast or colorectal cancer, either metastatic or non-metastatic
* Signed informed consent
Exclusion Criteria:
* Clinically significant cardiovascular diseases (atrial fibrillation, congestive heart failure, cardiomyopathies, or inherited arrhythmic syndromes)
* Known autoimmune diseases or immunodeficiencies
* Use of high-dose immunosuppressive drugs or other experimental treatments that could interfere with the assessment of study endpoints
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT07364656
Study Brief:
Protocol Section:
NCT07364656